Leukemia Posts on Medivizor
Navigation Menu

Leukemia Posts on Medivizor

Should ALL patients undergoing induction therapy be screened for virus infection?

Posted by on Oct 17, 2017 in Leukemia | 0 comments

In a nutshell This study examined the benefit of virus surveillance in patients undergoing induction therapy for acute lymphoblastic leukemia (ALL). This study concluded that many patients were at high risk for virus infection and screening during induction therapy could be helpful. Some background Leukemia patients who are undergoing stem cell...

Read More

What new developments have been made in immunotherapy for acute myeloid leukaemia?

Posted by on Oct 14, 2017 in Leukemia | 0 comments

In a nutshell This article aimed to review the latest developments in immunotherapy treatments for acute myeloid leukemia. This article concluded that the development of immunotherapies for acute myeloid leukemia is lagging behind that of other cancers. Some background Standard treatments for acute myeloid leukemia (AML) include chemotherapy,...

Read More

A 2017 update on CLL management

Posted by on Oct 12, 2017 in Leukemia | 0 comments

In a nutshell This study reviewed recent evidence on the management of chronic lymphocytic leukemia (CLL). Some background CLL is cancer of the blood and bone marrow. It is one of the most common types of leukemia in adults. The average age at diagnosis ranges from 67 to 72 years. Standard therapy for CLL usually involves a combination of...

Read More

Possible new treatment for younger acute myeloid leukemia patients in first remission

Posted by on Oct 12, 2017 in Leukemia | 0 comments

In a nutshell This study aimed to evaluate if a clofarabine-based combination would be suitable as a post-remission chemotherapy in younger patients with acute myeloid leukemia. This study concluded that a clofarabine-based combination may be considered as a post-remission chemotherapy in younger patients with acute myeloid leukemia.  Some...

Read More

Do male survivors of childhood acute lymphoblastic leukemia have reduced sexual function?

Posted by on Oct 12, 2017 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if childhood acute lymphoblastic leukemia affected sexual functioning in young male survivors. This study concluded that men who had childhood acute lymphoblastic leukemia had reduced sexual functioning when compared to men with no history of cancer.  Some background Male survivors of childhood...

Read More

Reducing the dosage of dasatinib does not prevent a second occurrence of fluid build-up in the lungs

Posted by on Oct 12, 2017 in Leukemia | 0 comments

In a nutshell This study examined a side effect called pleural effusion (PE; fluid build-up in the lungs) in patients with chronic myeloid leukemia (CML) treated with dasatinib (Sprycel). PE occurred in 23% of patients. This study concluded that reducing the dose of dasatinib after the first occurrence of PE did not prevent a recurrence.  Some...

Read More

Is hyperthyroidism a consequence of hematopoietic stem cell transplant for acute myeloid leukemia patients?

Posted by on Oct 12, 2017 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the thyroid function in acute myeloid leukemia (AML) patients who were treated with allogeneic hematopoietic stem cell transplant (allo-HSCT). This study concluded that a significant number of AML patients treated with allo-HSCT experience hyperthyroidism.  Some background An allogeneic...

Read More

Infection risk during ALL treatment

Posted by on Oct 7, 2017 in Leukemia | 0 comments

In a nutshell This study examined the risk of infection in childhood acute lymphoblastic leukemia patients. This study concluded that certain factors were associated with an increased risk of infection. These included age, race, and higher risk leukemia. Some background Improvements in treatment options for acute lymphoblastic leukemia (ALL) has...

Read More

Comparing the side effects of tyrosine kinase inhibitors for chronic myeloid leukemia patients

Posted by on Oct 5, 2017 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the incidence of pulmonary hypertension in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. This study concluded that treating CML patients with tyrosine kinase inhibitors can lead to mild pulmonary hypertension. Some background Tyrosine kinase inhibitors (TKIs) are a...

Read More